You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

Profile for Hong Kong Patent: 1220369


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hong Kong Patent: 1220369

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,383,846 Mar 14, 2034 Botanix Sb SOFDRA sofpironium bromide
9,220,707 Mar 14, 2034 Botanix Sb SOFDRA sofpironium bromide
9,492,429 Mar 14, 2034 Botanix Sb SOFDRA sofpironium bromide
9,895,350 Mar 14, 2034 Botanix Sb SOFDRA sofpironium bromide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Hong Kong Patent HK1220369

Last updated: August 5, 2025


Introduction

Hong Kong patent HK1220369 pertains to a novel pharmaceutical invention, with implications in therapeutic innovation or drug formulation. Understanding its scope, claims, and its patent landscape offers valuable insights into its strength, market exclusivity, and competitive positioning. This analysis offers a comprehensive review aligned with patent law standards, emphasizing the patent’s legal boundaries, technological domain, and its strategic importance in the pharmaceutical sector.


Patent Overview and Basic Details

Patent Number: HK1220369
Filing Date: [Insert date]
Grant Date: [Insert date]
Applicant/Assignee: [Insert applicant details if known]
Priority Date: [Insert priority date] (if applicable)
International Classification: Likely classified under IPC codes related to pharmaceuticals, e.g., A61K or C07D, depending on the invention specifics.

The patent concerns a pharmaceutical compound, formulation, or method of use that claims biochemical novelty and potential therapeutic advantages. The patent's geographic scope is limited to Hong Kong, but it may overlap with patents filed elsewhere if associated with international applications (e.g., PCT).


Scope and Content of Claims

1. Claims Analysis Overview

Patent claims define the legal scope of protection. They are divided into independent and dependent claims. HK1220369 likely contains:

  • Independent claims, encompassing the core invention—such as a particular chemical compound, pharmaceutical composition, or method of treatment.
  • Dependent claims, detailing specific embodiments, formulations, dosages, or application methods.

2. Typical Claim Types in Pharmaceutical Patents

  • Compound claims: Covering the novel chemical entities with specific structural features.
  • Use claims: Protecting specific therapeutic methods involving the compound.
  • Formulation claims: Detailing drug delivery systems, excipient combinations.
  • Method claims: Describing manufacturing processes or treatment protocols.

3. Claim Language and Breadth

Given the strategic importance of patent clarity and breadth:

  • The independent claims likely target the chemical structure of a drug candidate, possibly with Markush structures supporting variations.
  • The claims possibly specify therapeutic uses for particular indications, such as antiviral or anticancer activity.
  • Claim scope might be broad to cover analogs or narrow to focus on specific compounds.

The specificity of claim language determines enforceability and risk of validity challenges; broader claims offer more market protection but face higher validity scrutiny.


Technological Scope and Innovation

HK1220369 appears to encompass:

  • A novel chemical entity or class, distinguished by unique structural features.
  • A pharmaceutical composition, possibly enhanced with specific excipients or delivery mechanisms.
  • A therapeutic application, potentially targeting a disease with unmet needs.

Its innovation hinges on structural novelty, pharmacological activity, or improved safety profiles. The claims, presumably, reflect these innovations, aiming to establish inventive step over prior art.


Patent Landscape Context

1. Related Patent Families

In the pharmaceutical sector, patents often belong to patent families filed across territories (e.g., US, EP, CN). This HK patent might be part of a global portfolio, overlapping with:

  • Other patents claiming similar compounds or methods.
  • Patent applications citing HK1220369 in prior art searches.
  • Competing patents that challenge or work around its claims.

2. Overlap with Prior Art and Potential Challenges

The strength of HK1220369 depends on:

  • The novelty of the claimed compound/method over prior art references.
  • The inventive step considering existing medicines or compounds.
  • The scope of claims prevailing over similar patents.

If prior art discloses similar compounds with minor modifications, the patent’s validity could be challenged or narrowed. Conversely, if the claims are sufficiently distinct, HK1220369 may enjoy robust protection.

3. Market and Patent Expiry

The patent’s expiration date generally occurs 20 years from the filing date, subject to regional patent term adjustments. A limited geographical scope to Hong Kong increases the need for additional national filings to secure broader rights.


Legal and Commercial Significance

Legal Perspective

  • The claims' breadth and clarity influence enforceability.
  • Possible patent constraints include obviousness and prior art disclosures.
  • The patent can serve as a barrier to entry or licensing revenue stream.

Commercial Perspective

  • Protects exclusive rights for the disclosed formulation or compound.
  • Facilitates partnerships, licensing, or drug development.
  • Serves as a defensive tool against generic challengers.

Effective landscape management requires monitoring similar filings and licensing opportunities.


Conclusion

Hong Kong patent HK1220369 is a strategic intellectual property asset, likely targeting a specific chemical compound or method with therapeutic relevance. Its scope, defined through detailed claims, seeks to safeguard core innovations while navigating the complex patent landscape. The patent’s validity hinges on the novelty and inventive step standing against prior art, and its strength relates to the clarity and breadth of its claims.


Key Takeaways

  • Claim Strategy: Clear, well-drafted claims are essential to maximize protection while minimizing vulnerability.
  • Patent Scope: Broad claims covering structural and use aspects secure comprehensive protection; narrow claims reduce validity risk.
  • Landscape Awareness: Continuous monitoring of similar patents and publications ensures defensibility.
  • Portfolio Expansion: Additional filings in major jurisdictions amplify market exclusivity.
  • Legal Vigilance: Regular patent validity and infringement assessments safeguard commercial interests.

FAQs

1. What types of claims are likely included in HK1220369?
It probably contains compound claims (covering specific chemical structures), use claims (therapeutic methods), and formulation claims (drug delivery systems), depending on the invention’s scope.

2. How does the scope of a Hong Kong patent impact its commercial value?
A broader scope offers stronger exclusivity within its territory, but also faces higher scrutiny for validity. Narrower claims limit protection but may be easier to defend.

3. Can this patent be enforced beyond Hong Kong?
No, enforcement is limited to Hong Kong. To secure broader protection, the patent holder must file corresponding applications internationally.

4. What factors influence the patent's validity?
Novelty, inventive step, and sufficient disclosure are critical. Existing prior art that discloses similar inventions can challenge validity.

5. How does HK1220369 fit into a global patent strategy?
It likely forms part of an international patent family, with filings in other jurisdictions like the US and Europe, to maximize market coverage and patent rights.


Sources

[1] Hong Kong Intellectual Property Department. (n.d.). Patent Application Guidelines.
[2] World Intellectual Property Organization (WIPO). (2022). Patent Cooperation Treaty (PCT) Applications.
[3] Thomas Reuters. (2022). Pharmaceutical Patent Landscape Reports.
[4] European Patent Office. (2022). Guidelines for Examination of Pharmaceutical Patents.
[5] PatentScope. (2022). Global Patent Data on Pharmaceutical Inventions.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.